Title - COMPOUNDS 4-(4-(4-(((2-(2,6-DIOXOPIPERIDIN-3-YL)-1-OXOISOINDOLIN-4-YL)OXY)METHYL)BENZYL)PIPERAZIN-1-YL)-3-FLUOROBENZONITRILE AND SAID COMPOUNDS FOR USE IN A METHOD OF TREATING MULTIPLE MYELOMA

AR112268B1Active Publication Date: 2026-08-26CELGENE CORP
View PDF 0 Cites -1 Cited by

Patent Information

Application Number
ARP20180101905
Authority / Receiving Office
AR · AR
Patent Type
Patents
Current Assignee / Owner
Priority Date
2018-05-23
Filing Date
2018-07-06
Publication Date
2026-08-26
Estimated Expiration
2038-07-06
Patent Text Reader

Abstract

4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile, or an enantiomer, a mixture of enantiomers, a tautomer, or a pharmaceutically acceptable salt thereof, and methods for treating, preventing, or managing multiple myeloma using such compounds are provided. Also, pharmaceutical compositions comprising the compounds, and methods of using the compositions. Claim 1: A compound wherein the compound is Compound 1 of formula (1) or an enantiomer, mixture of enantiomers, tautomer, isotopologue, or a pharmaceutically acceptable salt thereof.
Need to check novelty before this filing date? Find Prior Art

Claims

1. A compound characterized in that the compound is Compound 1 of formula (FORMULA 1) or an enantiomer, mixture of enantiomers, or a pharmaceutically acceptable salt thereof. Thirty claims follow.